Marta Echevarria on Muck Rack

Marta Echevarria

As seen in: Radio 3, JD Supra, Lexology, Dialnet - Universidad de La Rioja, Gràffica, Mondaq, Concurrences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marta

Contact Marta, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Italy Targets Greenwashing and Social Washing With Landmark New Rules

|
By Sarah Batley, Marta Echevarria, Marta Delgado Echevarría
| JD Supra
In Short The Situation: On March 24, 2026, Italy's Legislative Decree No. 30/2026 entered into force, transposing EU Directive 2024/825 ("Empowering Consumers for the Green Transition") into Italian law. The Decree significantly amends the Italian Consumer Code to address greenwashing and social washing in commercial communications.
Open in Who Shared Issue with article?

Validación de la capacidad del proceso de pasteurización de la albúmina humana para inactivar virus

|
By Marta Echevarria, Enrique Romero, Yordank Sánchez Martínez
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Validación de la capacidad del proceso de pasteurización de la albúmina humana para inactivar virus Marta Dubed Echevarría [1] ; Enrique Noa Romero [1] ; Ana Teresa Ramírez Más [2] ; Yordank Sánchez Martínez [1] ; Leonor Navea Leyva [1] ; Leonor Lobaina Leyva [1] ; Giselle Álvarez Seguí [1] [1] Laboratorio de Investigaciones del SIDA [2] Empresa Productora de Sueros y Hemoderivados Alberto Pessant Localización: Revista Cubana de Hematología,...
Open in Who Shared Issue with article?

The EU Pharma Package Is a Done Deal: a Holiday Gift, or Not? | JD Supra

|
By Marta Echevarria, Marta Delgado Echevarría, Yvan N. Desmedt, Christian Fulda
| JD Supra
In Short The Background: After more than two years of negotiation following the European Commission's April 2023 proposal to overhaul the EU pharmaceutical framework, the EU institutions have finally converged on a package. The Situation: The package aims to balance innovation incentives with earlier and broader access to medicines. Whether or not the right balance has been struck remains to be seen. It is now time to start preparing for the new rules.
Open in Who Shared Issue with article?
See all 34 licensed articles (35 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Marta

Contact Marta, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified